Literature DB >> 6237722

Ascending aortic blood velocity and acceleration using Doppler ultrasound in the assessment of left ventricular function.

E D Bennett, S A Barclay, A L Davis, D Mannering, N Mehta.   

Abstract

We have used a 2.2 MHz continuous-wave Doppler blood velocity meter (Bach-Simpson BVM 202) to measure ascending aortic blood velocity and acceleration, and have obtained from the velocity signal a noninvasive measure of stroke volume and cardiac output by combining the Doppler technique with M-mode echocardiography. In two separate studies we have systematically altered the loading conditions of the heart with lower body pressure; and the inotropic state of the heart with dobutamine (5 micrograms . kg-1 . min-1), and documented the changes in mean velocity (MV), maximum acceleration (MA), stroke volume (SV), cardiac output (CO) and left ventricular end-diastolic dimension (EDD) (M-mode echocardiography). Application of lower body pressure to subjects in a 30 degrees head-up tilt position caused a systematic increase in preload, as shown by a 9% increase in EDD, which raised SV by a maximum of 33% (p less than or equal to 0.001) and CO by 32% (p less than or equal to 0.01), thus showing a classical Starling response; whilst there was relatively little increase in MA. Conversely, infusion of dobutamine, an inotropic agent, caused a 29.2% increase in MA (p less than or equal to 0.01) with minimal increase in SV. Thus, the ability to measure ascending aortic blood velocity allows noninvasive monitoring of changes in both inotropic state and Starling function, with considerable ease and rapidity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6237722     DOI: 10.1093/cvr/18.10.632

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  16 in total

1.  Use of exercise Doppler for non-invasive haemodynamic optimization of dose and identification of poor responders to an oral anti-anginal agent. A double-blind dose-finding study of nisoldipine.

Authors:  M Singer; I F Trotman
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

2.  Immediate ventilatory response to sudden changes in venous return in humans.

Authors:  A R Cummin; V I Iyawe; M S Jacobi; N Mehta; C P Patil; K B Saunders
Journal:  J Physiol       Date:  1986-11       Impact factor: 5.182

3.  Evaluation of cardiac function by echo-Doppler studies in critically ill patients.

Authors:  M Goldstein; J L Vincent; R J Kahn
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

4.  A possible explanation for the absence of anti-anginal properties of transdermal nitroglycerin units: an echocardiographic study.

Authors:  E D Bennett; A L Davis
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

5.  Assessment of magnetic resonance velocity mapping of global ventricular function during dobutamine infusion in coronary artery disease.

Authors:  D J Pennell; D N Firmin; P Burger; G Z Yang; C C Manzara; P J Ell; R H Swanton; J M Walker; S R Underwood; D B Longmore
Journal:  Br Heart J       Date:  1995-08

6.  Limits of corrected flow time to monitor hemodynamic status in children.

Authors:  E Wodey; F Carre; X Beneux; A Schaffuser; C Ecoffey
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

7.  Exercise electrocardiography and aortic Doppler velocimetry in asymptomatic identical twins discordant for type 1 (insulin dependent) diabetes.

Authors:  S Dubrey; F Akhras; G J Song; T Hardman; C Travill; J Hynd; M I Noble; S S Lo; R D Leslie
Journal:  Br Heart J       Date:  1994-04

8.  Comparative effects of angiotensin II on Doppler parameters of left and right heart systolic and diastolic blood flow.

Authors:  B J Lipworth; K D Dagg
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

9.  Cardiac function in healthy infants and children: Doppler echocardiographic evaluation.

Authors:  K Hanseus; G Björkhem; N R Lundström
Journal:  Pediatr Cardiol       Date:  1994 Sep-Oct       Impact factor: 1.655

10.  A placebo controlled comparison of the effects of metoprolol and celiprolol on echo-Doppler measurements of cardiovascular function in normal volunteers.

Authors:  B Silke; A Thompson; A Leitch; J G Riddell
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.